More proof of ALS Reversals

We are very pleased that the idea that ALS is reversible is becoming more and more accepted. Yesterday the Wall Street Journal published an article featuring 2 people who have reversed their ALS symptoms significantly. Here is an excerpt:

“Richard Bedlack has treated more than 2,000 patients with ALS, the neurological condition also known as Lou Gehrig’s disease. Almost without exception, his patients get worse over time and eventually die.

Now, Dr. Bedlack, longtime head of Duke University’s ALS clinic, is focusing on a different kind of patient: someone who seems to be getting better.

ALS, or amyotrophic lateral sclerosis, progressively robs people of the ability to move their muscles and is fatal, usually within two to five years.

But in a small number of cases—Dr. Bedlack says he has verified 23 so far—patients report unexpectedly regaining lost motor functions for at least a year. Some attribute their improvement to supplements or experimental therapies, but acknowledge they can’t be certain why they started to improve.

Dr. Bedlack believes that studying these so-called “ALS reversals” and trying to determine what, if anything, separates these individuals from the overwhelming majority of others may lead to new understanding of the disease and, potentially, new therapies…”

For the full article, see: or

We applaud Dr. Bedlack for studying these reversals and believe that this is most valuable way to come quickly to viable treatments for ALS.

We do want to emphasize that we feel ALS has many causes and not only are these causes different for each individual diagnosed but each person’s genetic and environmental background are different. Therefore, this means that treatment for each person will be highly individual, and what is successful for one, might not be successful for another. Different things work for different people. This is consistent with the vast majority of PALS (persons diagnosed with ALS) who have been able to successfully reverse ALS. They did a whole combination of protocols to reverse their ALS symptoms. We are convinced that the approach of studying only one protocol at a time is not ever going to work for the majority of ALS patients therefore we are hoping ALS researchers will move towards studying this multi-therapeutic approach in their clinical trials.

That said, we are very encouraged that ALS reversals are becoming accepted in the mainstream ALS community, and we thank Dr. Bedlack for his hard work by verifying the reversals of ALS in these patients, by studying them and beginning clinical trials, and by getting this information to the ALS medical community. We hope there will be more research funded to study the various multi-therapeutic approaches, these PALS have taken to reverse ALS.

Below is a recent YouTube video of Richard Bedlack, MD, PhD giving a talk describing some of his reversals.

Again, our hope is that the ALS research community studies a multi-therapeutic approach to ALS. Although Lunasen is in itself multi-therapeutic because the various ingredients address more than on thing in the body, it only addresses some of the possible causes of ALS. By addressing all the many possible causes of ALS with appropriate therapies, we believe the success rate will be much higher and more and more ALS patients will be able to reverse their symptoms. Again, thank you Dr. Bedlack for your contribution to solving the ALS puzzle.